Gliofibroma: a case report and review of the literature. by Kim, Yoonjung et al.
INTRODUCTION
Gliofibroma is a very rare bimorphic neoplasm composed
of both glial and mesenchymal components (1-5). The term,
gliofibroma, was first introduced by Friede in 1978 (6). Since
this initial report, about 23 cases have been reported (1-17)
mostly in the first two decades of life (1). Because of the paucity
of the literature with regard to this neoplasm, its exact biologi-
cal behavior is not fully known (1-4). In the World Health
Organization classification of tumors of the nervous system, the
gliofibroma was not included as a distinct entity (18).
We herein present a case of gliofibroma involving the left
parietal region in a young adult man, describing the histologic
findings and immunohistochemical profile including MIB-1
and p53, with a review of the literature. This is the first case
report of gliofibroma in Korea.
CASE REPORT
The patient was a 25-yr-old man who had suffered from gen-
eralized tonic clonic seizure for 6 months. The seizure was ac-
companied by tingling sense as a prodromal symptom. A ma-
gnetic resonance scan of the brain showed an enhancing mass
occupying the left parietal lobe with a central area displaying
low signal intensity. Since this lesion showed high attenuation
on computed tomographic scan, it was considered to be calci-
fication. He underwent gross total excision of the mass under
the clinical and radiological diagnosis of oligodendroglioma or
metastatic tumor. At operation, the mass was firmly palpable
at the cortical surface and located in the deep cortex. Neither
chemotherapy nor radiotherapy was given. For 2 months after
the operation, the patient showed no symptoms or signs of
recurrence of tumor.
On gross examination, the submitted specimen was a hard
mass with attached mucoid tissue, measuring 3.2×2.6×2.2
cm. On sections, the hard mass measured about 1.5 cm and
exhibited calcified areas.
Under the light microscope, the tumor was a relatively well
circumscribed mass without encapsulation but showed an infil-
trative growth pattern (Fig. 1). The tumor consisted of round-
to-oval and spindle cells and abundant extracellular collagenous
stroma. Tumor cells were arranged in small groups or islands
separated by bundles of fibrous connective tissue in most areas.
There was extensive calcification in the sclerotic tumor tissue
(Fig. 2). The cellularity of tumor varied from area to area and
was closely related with the abundance of collagenous stroma.
In areas with abundant hyalinized collagenous stroma, fib-
roblast-like spindle cells and tumor cells were sparsely scat-
tered (Fig. 3A). The periphery of the tumor showed hypercel-
lular aggregates of small round cells with a scanty collagenous
stroma (Fig. 3B). The nuclei of tumor cells were round to oval
or elongated with a fine chromatin pattern and perinuclear halo
(Fig. 3B). The nuclei were not uniform, and angulated nuclei
and nuclear grooves were frequently observed. Some round-to-
spindle cells showed wavy cellular processes. Neither mitosis
nor necrosis was observed throughout the tumor tissue. The
tumor was hypervascular with sclerosis of the vascular wall. The
collagenous tissue in the tumor was strongly stained with Mas-
son-trichrome. The reticulin stain showed abundant reticulin
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Gliofibroma: A Case Report and Review of the Literature
Gliofibroma is a rare astrocytic tumor, composed of a glial component ranging from
benign to high grade of malignancy and a consistently benign mesenchymal com-
ponent. Its exact biological behavior is not fully known. In addition, histogenesis
and prognostic factors are also still debatable. We herein present a rare case of
gliofibroma in a 25-yr-old male with seizure. A computed tomographic scan of the
brain showed a 1.5 cm-sized, enhancing mass with calcification. Histologically, the
tumor consisted of glial fibrillary acidic protein (GFAP)-positive glial cells admixed
with a mesenchymal component and extensive collagen lay down. The glial cells
displayed variable cellularity, but without mitosis or necrosis. Since the MIB-1 label-
ing index was up to 35.8% in the cellular areas of the glial component, it could be
considered to be a predictor of worse prognosis.
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fibers outlining the islands or nests of tumor cells (Fig. 4). The
tumor cells lacked periodic acid-Schiff (PAS)-positive mucin or
glycogen in their cytoplasm.
Immunohistochemically, most of the round-to-elongated
tumor cells were strongly reactive for glial fibrillary acidic pro-
tein (GFAP) (dilution 1:3,000; Biogenex, CA, U.S.A.), vime-
ntin (dilution 1:80; DAKO, Glostrup, Denmark), and S-100
protein (dilution 1:2,000; DAKO). Their cellular processes
were evident by GFAP immunostain (Fig. 5A, B). None of the
tumor cells expressed EMA (dilution 1:50; DAKO) or cytok-
eratin AE1/AE3 (dilution 1:80; Zymed, San Francisco, CA,
U.S.A.). There were some spindle cells that were GFAP-
negative but vimentin-positive (Fig. 5C). However, tumor
cells were negative for phosphorylated neurofilament (dilu-
Fig. 1. Histologically, the tumor is relatively well circumscribed (ar-
rows) and shows reactive gliosis in the surrounding brain parenchy-
ma (Masson-trichrome stain, ×200).
Fig. 2. Tumor cells are arranged in small groups or islands in most
areas with abundant collagen deposit and calcification (H&E stain,
×200).
Fig. 3. The tumor contains a sparse population of fibroblast-like spindle cells and glial cells in abundant connective tissue stroma (A, H&E
stain, ×200). Hypercellular areas of the tumor with scanty collagenous stroma show round to oval and elongated nuclei with an irregular
contour and perinuclear halo (B, H&E stain, ×400).
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tion 1:200; Biogenex, CA, U.S.A.) or synaptophysin (dilution
1:40; DAKO), in contrast to the strong expression in the
entrapped neurons. p53 (dilution 1:80; Zymed) was not ex-
pressed in tumor cells. MIB-1 (dilution 1:50; DAKO) was
almost negative in the sclerotic areas of the tumor, but its label-
ing index was up to 35.8% in the cellular areas of the tumor
periphery. These histologic and immunohistochemical find-
ings of the tumor were consistent with a gliofibroma.
DISCUSSION
Since the first description of gliofibroma in 1978, only spo-
radic cases of tumors designated as “gliofibroma” have ap-
peared in the literature (1-17). Table 1 summarizes the clinical
and histologic findings of the cases. The tumor showed no ap-
parent gender predilection. It has been described as arising
both in the supratentorial and infratentorial regions, including
several cases developing in the spinal cord. The age at presen-
tation varies, although most patients were in the first two de-
cades of life. There are several adult cases including the present
patient. Histologically, the majority of these neoplasms have
a benign histology and show no recurrence or metastasis after
resection. Necrosis and prominent vascular proliferation are
not typical features of gliofibroma (2). However, five cases
showed anaplastic or malignant features in their glial compo-
nent, such as increased mitotic activity and cellularity, abnormal
mitosis, and marked nuclear pleomorphism (1, 3, 6, 10, 11).
Among them, four patients died of the disease (1, 4, 6, 10).
Gliofibroma display either close intermingling of mesenchy-
mal (fibroblastic) and glial tissues or alternate areas of glial and
fibroblastic elements (1, 2). Our case showed the former pat-
tern. The glial cells of the present case showed fried-egg appea-
rance or artifact of oligodendroglioma, but their nuclear fea-
tures with angulated nuclei and nuclear grooves were reminis-
cent of astrocytoma. Moreover, astrocytic differentiation of
those cells was confirmed by immunohistochemistry for GFAP.
Clear cell changes of the glial element and extensive perivascu-
lar sclerosis were considered to be unique features of the present
case, as compared with previously reported cases (1-7, 10, 11,
13-15, 17).
Among the rare bimorphic neoplasms of mixed mesenchy-
Fig. 4. The tumor contains abundant reticulin fibers outlining the
islands or nests of tumor cells (reticulin stain, ×200).
Fig. 5. Results of immunohistochemical stains. (A, B) Most of the tumor cells are strongly reactive for GFAP, and their cellular processes are
evident by GFAP immunostains (×400). (C) Some spindle cells are GFAP-negative but vimentin-positive (×400).
A B C628 Y. Kim, Y.-L. Suh, C. Sung, et al.
mal and glial elements, gliosarcoma is the most common and
well-recognized lesion comprised of a malignant astrocytic
component (glioblastoma) and also a malignant mesenchymal
component (sarcoma) (1, 2). The sarcomatous element is fre-
quently accompanied by an increased deposition of collagen
material (2). In gliofibroma with a malignant behavior, the
glial component exhibits features of anaplasia, while the his-
tology of mesenchymal component is consistently benign (1).
Unfortunately the term “gliofibroma’’ has been used in the lit-
erature for both benign and malignant forms. Actually the
prognostic factors of the tumor are still a matter of debate (1).
Nevertheless, the MIB-1 or Ki-67 antibody appears to be a
marker of cell proliferation (1). The present case showed focal
areas with increased celluarity in the glial element of tumor,
in which the MIB-1 index was 35.8%. The MIB-1 index of
our case is the highest among the gliofibroma cases reported
in the literature (1, 2, 17). With existence of high cellular area,
the high Ki-67 positivity may be considered to be a possible
predictor of worse prognosis.
Histologically, gliofibromas should be distinguished from
other collagen-producing tumors of the central nervous system,
including clear cell meningioma, gliosarcoma, and desmoplas-
tic infantile astrocytoma and ganglioglioma (DIA/DIG). Clear
cell meningioma is easily excluded by the negative EMA stain-
ing of the tumor cells. In addition, the cells have no PAS-posi-
tive cytoplasmic glycogen. Gliosarcoma can be distinguished
by the presence of a malignant mesenchymal element. Gliofi-
broma may be included under a broader category of desmoplas-
tic astrocytic tumors with DIA/DIG (2, 13, 19). In spite of
their striking similarities, there are also several differences,
Authors, Year 
(Reference)
Case
No.
Age (yr),
Sex
Location of tumor Pathologic findings Treatment Outcome
(duration of follow-up)
Friede 1978 (6) 1 3.7, F Lower medulla Dedifferentiation in the glial RT/chemoT No surgery
component  Died 3 mos
after presentation
Budka and Sunder-Plassmann  2 45, F Cervical spinal cord Moderately increased  Surgery (GTR) Alive (1 yr)
1980 (7) cellularity in the glial component
Iglesias et al. 1984 (5) 3 11 days, M Thoracic spinal cord Benign gliofibroma Surgery (GTR) Alive (4 yr)
Reinhardt et al. 1984 (8) 4 16, F Rt temporal lobe NA Surgery Alive (6 mos)
Bonin et al. 1990 (9) 5 32, F 4th ventricle NA NA NA
Snipes et al. 1991 (10) 6 2 mo, F Thalamus, post. Increased MFs in the  Surgery (STR) Died (16 mos)
fossa glial component
Vazquez et al. 1991 (4) 7 9, F spinal cord (C, T) Benign gliofibroma Surgery (STR)/RT Died (1.5 yr)
8 5.5, M spinal cord (T, S) Benign gliofibroma Surgery (GTR)/RT Alive (2.5 yr)
9 11 mo, F Rt temporal lobe Foci of pleomorphism and  Surgery (GTR) Alive (2 yr)
numerous MFs in the glial
component
Schober et al. 1992 (11) 10 18, M Rt frontal lobe Small foci of anaplasia and  Surgery (GTR) Alive (7 days)
giant cells in the glial component
Iglesias-Rozas et al. 1992 (12) 11 14 mo, F Lt frontoparietal lobe NA Surgery Alive (18 mos)
Rushing et al. 1993 (13) 12 6 mo, F Posterior fossa Benign gliofibroma Surgery (GTR) Alive (2 yrs)
Cerda-Nicolas et al. 1993 (14) 13 9, M Lt parietal lobe Benign gliofibroma Surgery (GTR) Alive (5.5 mos)
14 4, F 4th ventricle Foci of increased cellularity &  NA NA
giant cells in the glial component
Windisch et al. 1995 (15) 15 5 mo, M T10-11 Benign gliofibroma, abundant Surgery (STR) Alive (7 mos)
small thick-walled vessels
Caldemeyer et al. 1995 (3) 16 8, M Temporal lobe Numerous MFs and increased chemoT NA
cellularity in the glial component
17 6 mo, F Cerebellum Benign gliofibroma Surgery (GTR) NA
Prayson, 1996 (2) 18 3 mo, M Lt frontoparietal lobe Benign gliofibroma  0.9% of PI Surgery (STR) Alive (31 mos)
Molenkamp et al. 1998 (16) 19 NA NA NA NA NA
Sharma et al. 1998 (1) 20 24, F T6-8 Benign gliofibroma 0% of PI Surgery (STR) Alive (2 yr)
21 10, M Temporal lobe Benign gliofibroma 0% of PI Surgery (GTR) Alive (3 mos)
22 54, F Rt parietal lobe Increased cellularity and  Surgery (GTR)/RT Died (6 mos)
MFs in the glial component,
10.5% of PI
Matsumura et al. 2002 (17) 23 12, F Cervical spinal cord Increased cellularity 1% of PI Surgery (GTR) Alive (33 mos)
Present case, 2003 24 25, M Lt parietal lobe Foci of increased cellularity Surgery (GTR) Alive (2 mos)
up to 35.8% of PI
Table 1. Clinical findings of gliofibromas reported in the literature
NA: not available, C: cervical, T: thoracic, S: sacral, Rt: right, Lt: left, RT: radiation therapy, chemoT: chemotherapy, GTR: gross total resection, STR:
subtotal resection, yr: year, mo: month, MFs: mitotic figures, PI: proliferation index.A Case Report of Gliofibroma 629
DIA/DIG are presented as a large cystic lesion in the superfi-
cial cortex of the brain and usually affect infancy or early child-
hood. DIA/DIG is considered to be a benign neoplasm (WHO
grade I) with a low MIB-1 labeling index less than 5% (20).
In DIA/DIG, the mesenchymal fibroblastic element is absent.
In the present case, clear cell features of the glial component
resembled those of glioneuronal tumors such as neurocytoma,
which prompted us to do immunostain using the neuronal
markers and electron microscopic study. However, tumor cells
showed no evidence of neuronal differentiation.
The most salient feature of these desmoplastic neoplasms
may be their ability to generate connective tissue elements, for
which a number of hypotheses have been advanced (2). Friede
(6) proposed that collagen was produced by multipotential
glial/mesenchymal cells. Iglesias et al. (5) demonstrated that
collagen was produced by fibroblasts. On the other hand, there
also have been some theories suggesting glial cells as the source
of collagen via: 1) fibroblastic metaplasia (13), 2) secondary
differentiation (21), or 3) generation of growth factors resulting
in a proliferation of certain mesenchymal cell types (2).
Although some authors put gliofibroma in the same catego-
ry with desmoplastic astrocytic tumors (2, 13, 19), the disease
is a distinct entity (1, 22). Depending upon the presence of
features of anaplasia in the glial component, this tumor should
be labeled as a benign or malignant gliofibroma and treated
accordingly (1).
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